Global Sildenafil Citrate (Cas 171599-83-0) Market Insights, Forecast and Analysis 2016-2021: Hexa Reports

Hexa Reports
Market Research Reports and Insightful Company Profiles

Global Sildenafil Citrate (CAS 171599-83-0) Market Share,
Size, Emerging Growth and Trends, Outlook and Overview,
Forecast and Analysis 2016-2021

This report provides detailed analysis of worldwide markets for Sildenafil Citrate (CAS 171599-83-0)
from 2011-2016, and provides extensive market forecasts (2016-2021) by region/country and
subsectors. It covers the key technological and market trends in the Sildenafil Citrate (CAS 171599-83-0)
market and further lays out an analysis of the factors influencing the supply/demand for Sildenafil
Citrate (CAS 171599-83-0), and the opportunities/challenges faced by industry participants. It also acts
as an essential tool to companies active across the value chain and to the new entrants by enabling
them to capitalize the opportunities and develop business strategies.
Sildenafil citrate, sold as Viagra, Revatio and under various other trade names, is a drug used to treat
erectile dysfunction and pulmonary arterial hypertension (PAH). It was originally discovered by Pfizer
scientists Andrew Bell, David Brown, and Nicholas Terrett. It acts by inhibiting cGMP-specific
phosphodiesterase type 5 (PDE5), an enzyme that promotes degradation of cGMP, which regulates
blood flow in the penis. Since becoming available in 1998, sildenafil has been the prime treatment for
erectile dysfunction; its primary competitors on the market are tadalafil (Cialis) and vardenafil (Levitra).
Browse Detail Report With TOC @
GCC's report, Global Sildenafil Citrate (CAS 171599-83-0) Market Forecast and Analysis 2016-2021, has
been prepared based on the synthesis, analysis, and interpretation of information about the global

Hexa Reports
Market Research Reports and Insightful Company Profiles
Sildenafil Citrate (CAS 171599-83-0) market collected from specialized...